# Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

> **NCT01596426** · PHASE1 · WITHDRAWN · sponsor: **Kyowa Kirin Pharmaceutical Development Ltd**

## Conditions studied

- Chemotherapy Induced Nausea and Vomiting

## Interventions

- **DRUG:** Sancuso
- **DRUG:** IV granisetron

## Key facts

- **NCT ID:** NCT01596426
- **Lead sponsor:** Kyowa Kirin Pharmaceutical Development Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The company currently does not have plans to conduct this study
- **Last updated:** 2024-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01596426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01596426, "Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01596426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*